Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Nasser (Bron, France). Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis. 4876

Member's Comments

No comment yet.

Related content which might interest you: Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia Source: ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020 Year: 2021 The health status in idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents Source: Eur Respir J 2014; 44: 523-527 Year: 2014 Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Rare diseases Year: 2017 Clinical investigation of idiopathic pleuroparenchymal fibroelastosis cases diagnosed by radiologic findings and fibroelastosis obtained by TBLB Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Source: Eur Respir J 2013; 41: 243-245 Year: 2013 Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Pleuroparenchymal fibroelastosis (PPFE) – Resembling features in patients with malignancies Source: International Congress 2015 – IIPs: orphan Year: 2015 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018 Registry of idiopathic pulmonary fibrosis patients Source: International Congress 2016 – Russia Session Year: 2016 Long-term safety of combination therapy with nintedanib and pirfenidone in Japanese patients with IPF Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016